| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,171 |
18,648 |
$1.05M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,711 |
10,897 |
$470K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,922 |
6,551 |
$240K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,204 |
8,475 |
$171K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,501 |
2,351 |
$137K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,109 |
11,306 |
$95K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,259 |
1,181 |
$93K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,151 |
2,023 |
$63K |
| 87428 |
|
433 |
422 |
$23K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
40 |
29 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
431 |
409 |
$17K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
52 |
30 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
281 |
260 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
173 |
169 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
693 |
578 |
$5K |
| 81003 |
|
1,929 |
1,766 |
$3K |
| 86328 |
|
39 |
38 |
$1K |
| 85027 |
|
177 |
151 |
$381.34 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
14 |
13 |
$144.22 |
| 90756 |
|
12 |
12 |
$50.00 |
| Q0240 |
Injection, casirivimab and imdevimab, 600 mg |
89 |
43 |
$0.00 |